Regarding HD patients, the large majority of studies reported increased TBARS levels in the plasma compared to healthy individuals [48, 63, 67–70], reflecting extensive lipid peroxidation, while erythropoietin treatment can help mitigate redox disturbances and inflammation, especially in the long term [70]. Here, EPO is linked to Huntington disease.